These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15212723)

  • 21. How cost-effective are new preventive strategies for cardiovascular disease?
    Probstfield JL
    Am J Cardiol; 2003 May; 91(10A):22G-27G. PubMed ID: 12781905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Chan WV; Pearson TA; Bennett GC; Cushman WC; Gaziano TA; Gorman PN; Handler J; Krumholz HM; Kushner RF; MacKenzie TD; Sacco RL; Smith SC; Stevens VJ; Wells BL
    J Am Coll Cardiol; 2017 Feb; 69(8):1076-1092. PubMed ID: 28132746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reassessment of the cost-effectiveness of water and sanitation interventions in programmes for controlling childhood diarrhoea.
    Varley RC; Tarvid J; Chao DN
    Bull World Health Organ; 1998; 76(6):617-31. PubMed ID: 10191558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic Evaluation of an Internet-Based Preventive Cognitive Therapy With Minimal Therapist Support for Recurrent Depression: Randomized Controlled Trial.
    Klein NS; Bockting CL; Wijnen B; Kok GD; van Valen E; Riper H; Cuijpers P; Dekker J; van der Heiden C; Burger H; Smit F
    J Med Internet Res; 2018 Nov; 20(11):e10437. PubMed ID: 30478021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study.
    Megiddo I; Chatterjee S; Nandi A; Laxminarayan R
    Glob Heart; 2014 Dec; 9(4):391-398.e3. PubMed ID: 25592792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.
    Chambers JD; Lord J; Cohen JT; Neumann PJ; Buxton MJ
    Value Health; 2013 Jun; 16(4):629-38. PubMed ID: 23796298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association.
    Weintraub WS; Daniels SR; Burke LE; Franklin BA; Goff DC; Hayman LL; Lloyd-Jones D; Pandey DK; Sanchez EJ; Schram AP; Whitsel LP; ; ; ; ; ; ; ;
    Circulation; 2011 Aug; 124(8):967-90. PubMed ID: 21788592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimorbidity in chronic disease: impact on health care resources and costs.
    McPhail SM
    Risk Manag Healthc Policy; 2016; 9():143-56. PubMed ID: 27462182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human papillomavirus vaccination: a review of the cost-effectiveness studies.
    Giraldi G; Martinoli L; De Luca d'Alessandro E
    Clin Ter; 2014; 165(6):e426-32. PubMed ID: 25524200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
    Warden BA; Shapiro MD; Fazio S
    Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.
    Saha S; Hoerger TJ; Pignone MP; Teutsch SM; Helfand M; Mandelblatt JS;
    Am J Prev Med; 2001 Apr; 20(3 Suppl):36-43. PubMed ID: 11306230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
    Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
    Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.
    Bambha K; Kim WR
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):519-26. PubMed ID: 15167152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness Analysis of Humanitarian Hand Surgery Trips According to WHO-CHOICE Thresholds.
    Qiu X; Nasser JS; Sue GR; Chang J; Chung KC
    J Hand Surg Am; 2019 Feb; 44(2):93-103. PubMed ID: 30579691
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.